IVIG (Gamunex-C) Treatment Study for POTS Subjects

NCT03919773 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Postural Tachycardia Syndrome

Interventions

DRUG: IVIG
DRUG: Albumin

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]